Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia clinical trials

Explore recruiting progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia clinical trials.

Also recruiting in Europe

Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Tezepelumab (Anti-TSLP-mab) in progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia - A prospective two-armed, phase II clinical multicentre randomized, placebo-controlled (2:1), blinded with open-label extension trial (TEFIBEOS)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia trials by city

Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Toronto Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Vancouver Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Montreal Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Calgary Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Edmonton Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Ottawa Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Winnipeg Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Quebec City Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Hamilton Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Kitchener Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in London Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Halifax Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in New York Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Los Angeles Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Chicago Progressive Pulmonary Fibrosis Interstitial Lung Disease With Evidence Of Eosinophilia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease